The laboratory aims to understand the biological mechanisms underlying the initiation and progression of malignant brain tumors , and to identify and characterize novel molecular targets for targeted therapies, including cell and gene therapy, against high grade gliomas.
COLLABORATIONS
National
- Neurosurgery Department Centre Hospitalier Luxembourg (CHL): Dr. F. Hertel
- Microarray Center, CRP-Santé: Dr. L. Vallar
- Flowcytometry Core Facility, CRP-Santé: NHC Brons
- University of Luxembourg : Prof. P. Heuschling, Prof. E. Friederich
- IBBL, Luxembourg
International
- University of Bergen, Norway, Molecular Imaging Center: Prof. F. Thorsen
- University of Umeå, Umeå, Sweden: Dr. H. Hedman (Radiation Oncology) and Dr. H. Antti (Department of Biological Chemistry)
- Translational Genomics Research Institute (TGen), Oncology Division, Brain Tumor Unit, Phoenix, Arizona: Dr. M. Berens
- University of Texas M. D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, Texas: Prof. V.A. Levin
- Institut National Polytechnique de Lorraine (INPL), Lipidomix Laboratory, Nancy, France: Dr. T. Pillot
- Netherlands Institute for Neurosciences, NeuroRegeneration Department, Amsterdam, NL: Prof. J. Verhaagen
- University of Groningen, Medical Biology, Groningen, NL: Prof. P. de Vos
- Vrije Universiteit (VU) Cancer Center, Amsterdam, Netherlands, Onco-Proteomics Facility: Dr. C. Jimenez
- Angiotargeting Consortium, EU Integrated Project 6th FP (11 partners). Website: www.uib.no/med/angiotargeting
- COST Action 865: Bioencapsulation multiscale interaction analysis (coordinator: Prof. D. Poncelet, France). Website: http://cost865.bioencapsulation.net